Electrocardiographic Changes in Chronic Obstructive Pulmonary Disease - An observational study from North-East of India
Abstract
Chronic obstructive pulmonary disease has got significant cardiovascular morbidity and mortality. The adverse cardiac effect can be picked up early by Electrocardiography (ECG) and echocardiography. Here, in this study, we tried to find out the different ECG changes in COPD and its correlation with disease duration, severity and other factors. We conducted a cross-sectional observational study in the Assam Medical College, Dibrugarh for a span of one year where 234 spirometrically confirmed COPD patients had undergone ECG. Most of the patients belonged to GOLD stage III (40%) and P-pulmonale was the most common ECG abnormality (63.3%). Other ECG findings were right axis deviation, right ventricular hypertrophy, incomplete right bundle branch block, S1Q3T3, S1Q3 pattern and Atrial Fibrillation (AF), having an increasing trend of abnormalities with the severity of GOLD stage. Increased incidence of AF is due to severity and longer duration of the disease. AF and right axis deviation occur more in smokers. Low voltage ECG is a nonspecific finding. The ECG changes were well correlated with disease severity and duration.
How to cite this article:
Pal A, Das A, Thakuria J. Electrocardiographic Changes in Chronic Obstructive Pulmonary Disease - An observational study from North-East of India. J Commun Dis 2020; 52(1): 32-37.
DOI: https://doi.org/10.24321/0019.5138.202005
References
Lozano R, Naghavi M, Foreman K et al. Global and regional mortality from 235 causes of death for 20
age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study. Lancet 2012;
(9859): 2095-2128.
Lee-Chiong TL, Matthay RA. The heart in the stable COPD patient. In: Similowski T, Whitelaw WA, Derenne
JP, editors. Clinical Management of Chronic Obstructive Pulmonary Disease. New York: Marcel Dekker; 2002:
-532.
Hunninghake D. Cardiovascular disease in chronic obstructive pulmonary disease. Proc Am ThoracSoc
; 2: 44-49.
Weitzenblum E, Hirth C, DucoloneA et al. Prognostic value of pulmonary artery pressure in chronic
obstructive pulmonary disease. Thorax 1981; 36: 752-758.
Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease: a 15-year
follow-up study. Am Rev Respir Dis 1979; 119: 895-902.
Sidney S, Sorel M, QuesenberryCPJr et al. COPD and incident cardiovascular disease hospitalizations and
mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128: 2068-2075.
Anthonisen NR, Connett JE, Kiley JP et al. Effects of smoking intervention and the use of an inhaled
anticholinergic bronchodilator on the rate of decline of FEV1: The Lung Health Study. JAMA 1994; 272(19):
-1505.
Sin DD, Anthonisen NR, Soriano JB et al. Mortality in COPD: Role of comorbidities. EurRespir J 2006; 28:
-1257.
Vij A, Kapila S, Vij C et al. Study of Electrocardiographic and Echocardiographic Profile of COPD patients. JAPI
; 56: 290.
Van Durme YMTA, Verhamme KMC, Stijnen T et al. Prevalence, incidence, and lifetime risk for the
development of COPD in the elderly: the Rotterdam study. Chest 2009; 135(2): 368-377.
Bischoff EW, Schermer TRJ, Bor HHJ et al. Trends in COPD prevalence and exacerbation rates in Dutch
primary care. Br J Gen Pract 2009; 59(569): 927-933.
Geijer RM, Sachs AP, Hoes AW et al. Prevalence of undetected persistent airflow obstruction in male
smokers 40-65 years old. FamPract 2005; 22(5): 485-489.
Padmavati S, Raizada V. Electrocardiogram in chronic corpulmonale. Br Heart J 1972; 34: 658-667.
Spodick, DH. Electrocardiographic studies in pulmonary disease; II: establishment of criteria for the
electrocardiographic influence of diffuse lung disease. Circulation 1959; 20: 1073-1074.
Chappell AG. The ECG in chronic bronchitis and emphysema. Br Heart J 1966; 28: 517.
Calatayud JB, Abod JM, Khoi NB et al. P wave changes in chronic obstructive pulmonary disease. Am Heart
J 1970; 79: 444.
Caird FI, Wilcken EL. The electrocardiogram in chronic bronchitis with generalized obstructive lung disease:
Its relation to ventilatory function. Am J Col 1962; 10(1): 5-13.
Arilli DA, Denson LJ, Timmapuri N. Electrocardiographic Estimation of Pulmonary Impairment in Chronic
Obstructive Lung Disease. Chest 1973; 63: 483-487.
Millard FJ. The electrocardiogram in chronic lung disease. Br Heart J 1967; 29: 43-50.
Milnor WR. The electrocardiogram and vectorcardiogram in right ventricular hypertrophy and right bundlebranch block. Circulation 1957; 16: 348-367.
Incalzi RA, Fuso L, Rosa MD et al. Co-morbidity contributes to predict mortality of patients with chronic
obstructive pulmonary disease. EurRespir J 1997; 10: 2794-2800.
Dhar MC, Chaudhuri S, Pain S et al. Electrocardiographic Changes in Chronic corPulmonale with Chronic
Obstructive Pulmonary Disease. JAPI 2002; 50.
Murphy ML, Hutcheson F. The Electrocardiographic Diagnosis of Right Ventricular Hypertrophy in Chronic
Obstructive Pulmonary Disease. Chest 1974; 65: 622-627.
Buch P, Friberg J, Scharling H et al. Reduced lung function and risk of atrial fibrillation in The Copenhagen
City Heart Study. EurRespir J 2003; 21: 1012-1016.
Flowers NC, Horan LG. Subtle signs of right ventricular enlargement and their relative importance. In:Schlant
RD, Hurst JW, editors. Advances in Electrocardiography. New York: Grune and Stratton, Inc.; 1972. 297-308.
Copyright (c) 2020 Journal of Communicable Diseases (E-ISSN: 2581-351X & P-ISSN: 0019-5138)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
